Combining infliximab, anti-MAP and hyperbaric oxygen therapy for resistant fistulizing Crohn's disease.

Agrawal, Gaurav; Borody, Thomas; Turner, Robert; Leis, Sharyn; Campbell, Jordana.

Afiliação

Agrawal G; Centre for Digestive Diseases, Level 1/229 Great North Rd, Five Dock NSW 2046, Australia; Centre for Digestive Diseases, Level 1/229 Great North Rd, Five Dock NSW 2046, Australia.
Borody T; Centre for Digestive Diseases, Level 1/229 Great North Rd, Five Dock NSW 2046, Australia; Centre for Digestive Diseases, Level 1/229 Great North Rd, Five Dock NSW 2046, Australia.
Turner R; Prince of Wales Hospital, 1st Floor, Edmund Blacket Building, Randwick NSW 2031, Australia; Prince of Wales Hospital, 1st Floor, Edmund Blacket Building, Randwick NSW 2031, Australia.
Leis S; Centre for Digestive Diseases, Level 1/229 Great North Rd, Five Dock NSW 2046, Australia; Centre for Digestive Diseases, Level 1/229 Great North Rd, Five Dock NSW 2046, Australia.
Campbell J; Centre for Digestive Diseases, Level 1/229 Great North Rd, Five Dock NSW 2046, Australia; Centre for Digestive Diseases, Level 1/229 Great North Rd, Five Dock NSW 2046, Australia.

Future Sci OA ; 1(4): FSO77, 2015 Nov.

Article em En | MEDLINE | ID: mdl-28031926